Literature DB >> 22176793

Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial.

Julie Chor1, Julia Bregand-White, Alex Golobof, Bryna Harwood, Allison Cowett.   

Abstract

BACKGROUND: Despite the high efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) in preventing pregnancy, uptake of the intrauterine devices remains low in the United States. Decreasing pain at the time of intrauterine device insertion may be one way to increase interest in this method of contraception. STUDY
DESIGN: We conducted a double-blind, placebo-controlled trial, randomizing women to 800 mg ibuprofen or placebo 45 min prior to LNG-IUS insertion to determine effect of ibuprofen on the pain of LNG-IUS insertion.
RESULTS: Eighty-one women completed the study: 44 received ibuprofen, and 37 received placebo. Women in the ibuprofen and placebo groups had similar mean scores for anticipated pain (4.07 and 3.91, respectively; p=.79), pain with tenaculum placement (3.86 and 3.81, respectively; p=.90) and pain with insertion (3.69 and 3.34, respectively; p=.91).
CONCLUSION: Administration of ibuprofen prophylaxis for LNG-IUS insertion does not decrease pain at the time of insertion.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22176793     DOI: 10.1016/j.contraception.2011.10.015

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial.

Authors:  Sheila K Mody; John Paul Farala; Berenice Jimenez; Moena Nishikawa; Lynn L Ngo
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

2.  Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial.

Authors:  Lynn L Ngo; Kristy K Ward; Sheila K Mody
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

3.  Intrauterine lidocaine and naproxen for analgesia during intrauterine device insertion: randomized controlled trial.

Authors:  Shana M Miles; Katerina Shvartsman; Susan Dunlow
Journal:  Contracept Reprod Med       Date:  2019-09-10

4.  Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial.

Authors:  Elaine Cristina Fontes de Oliveira; Thaís Baêta; Ana Paula Caldeira Brant; Agnaldo Silva-Filho; Ana Luiza Lunardi Rocha
Journal:  BMC Womens Health       Date:  2021-10-29       Impact factor: 2.809

Review 5.  Management of pain associated with the insertion of intrauterine contraceptives.

Authors:  K Gemzell-Danielsson; D Mansour; C Fiala; A M Kaunitz; L Bahamondes
Journal:  Hum Reprod Update       Date:  2013-05-12       Impact factor: 15.610

Review 6.  Interventions for pain with intrauterine device insertion.

Authors:  Laureen M Lopez; Alissa Bernholc; Yanwu Zeng; Rebecca H Allen; Deborah Bartz; Paul A O'Brien; David Hubacher
Journal:  Cochrane Database Syst Rev       Date:  2015-07-29

7.  A comparison of the expected and actual pain experienced by women during insertion of an intrauterine contraceptive device.

Authors:  Nataliya Brima; Hannat Akintomide; Vivian Iguyovwe; Susan Mann
Journal:  Open Access J Contracept       Date:  2015-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.